+54.4%
CVS vs AGNC
+62.2%
-7.8%
-44.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AGNC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -0.4% | -0.3% | -0.6% |
| 7D | -2.2% | -4.7% | +2.5% | -1.6% |
| 30D | -0.1% | -5.7% | +5.6% | +0.6% |
| 3M | -5.2% | +1.9% | -7.1% | -5.6% |
| 6M | +26.9% | +1.8% | +25.1% | +26.2% |
| YTD | +22.1% | +3.4% | +18.6% | +20.4% |
| 1Y | +30.8% | +13.6% | +17.2% | +26.7% |
| 3Y | +54.4% | +60.4% | -6.0% | +42.3% |
| All | +54.4% | +62.2% | -7.8% | +42.3% |
Cumulative growth
Daily Returns
Daily percentage return beside AGNC.
Daily Out/Under-Performance
Portfolio return minus AGNC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AGNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AGNC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling